Pharmacokinetics and Food Effect Between a 100-mg Sustained-Release Tablet and a 50-mg Immediate-Release Tablet of Vildagliptin in Healthy Subjects.

Yoo, Hyounggyoon; Shin, Wonsuk; Lee, BackHwan; Park, JinSoo; Lee, Yilseob; Kim, Anhye

Yoo, Hyounggyoon; Shin, Wonsuk; Lee, BackHwan; Park, JinSoo; Lee, Yilseob; Kim, Anhye.

Afiliação

Yoo H; Department of Clinical Pharmacology and Therapeutics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam-si, Gyeonggi-do, Republic of Korea.
Shin W; Department of Clinical Pharmacology and Therapeutics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam-si, Gyeonggi-do, Republic of Korea.
Lee B; Department of Clinical Development, Alvogen Korea, Yeongdeungpo-gu, Seoul, Republic of Korea.
Park J; Department of Clinical Development, Alvogen Korea, Yeongdeungpo-gu, Seoul, Republic of Korea.
Lee Y; Department of Clinical Pharmacology and Therapeutics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam-si, Gyeonggi-do, Republic of Korea.
Kim A; Department of Clinical Pharmacology and Therapeutics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam-si, Gyeonggi-do, Republic of Korea.

Clin Pharmacol Drug Dev ; 13(2): 122-127, 2024 02.

Article em En | MEDLINE | ID: mdl-37548105

Assuntos

Vildagliptina; Humanos; Voluntários Saudáveis; Estudos Cross-Over; Preparações de Ação Retardada/farmacocinética; Comprimidos

Palavras-chave

pharmacokinetics; sustained-release tablet; vildagliptin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vildagliptina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google